Welcome to our dedicated page for Apyx Medical Corporation news (Ticker: APYX), a resource for investors and traders seeking the latest updates and insights on Apyx Medical Corporation stock.
Apyx Medical Corporation (APYX) delivers innovative plasma-based energy systems for surgical and cosmetic applications. This news hub provides investors and medical professionals with timely updates on regulatory developments, product innovations, and strategic partnerships driving advancements in electrosurgical technology.
Access authoritative reporting on APYX's Advanced Energy segment developments, including Renuvion® system enhancements, and OEM manufacturing collaborations. Track financial performance updates, clinical study results, and market expansion initiatives critical to evaluating the company's position in medical device innovation.
Our curated news collection features earnings announcements, FDA clearances, research publications, and executive leadership changes. Stay informed about helium plasma technology applications in dermatology and general surgery through verified sources, maintained for accuracy and relevance.
Bookmark this page for streamlined access to APYX's evolving corporate narrative. Combine real-time updates with historical context to better understand this pioneer in energy-based surgical solutions.
Apyx Medical Corporation (NASDAQ:APYX) announced that it will release its financial results for Q1 of fiscal year 2023 before the market opens on May 11th. A conference call will follow at 8:00 a.m. Eastern Time on the same day, allowing for a discussion of the results and a Q&A session. Interested callers can join by dialing 877-407-8289 (or 201-689-8341 internationally) with access code 13737575. A live webcast will also be available through the Company’s Investor Relations section. This financial update is anticipated to provide insights into Apyx Medical's performance in the advanced energy technology market, including its innovative products Renuvion and J-Plasma, which are designed for cosmetic and hospital surgical applications.